Allspring Global Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$167M Buy
2,060,891
+1,419,022
+221% +$117M 0.28% 86
2025
Q4
$54.8M Buy
641,869
+613,017
+2,125% +$50.3M 0.09% 258
2025
Q3
$2.2M Sell
28,852
-1,211
-4% -$94.6K ﹤0.01% 1009
2025
Q2
$2.32M Sell
30,063
-132
-0.4% -$9.85K ﹤0.01% 1022
2025
Q1
$2.17M Buy
30,195
+145
+0.5% +$10.4K ﹤0.01% 1079
2024
Q4
$2.18M Sell
30,050
-293,797
-91% -$20.6M ﹤0.01% 1127
2024
Q3
$21.4M Sell
323,847
-225
-0.1% -$16.3K 0.03% 547
2024
Q2
$29.9M Sell
324,072
-6,639
-2% -$588K 0.05% 443
2024
Q1
$31.6M Buy
330,711
+14,087
+4% +$1.18M 0.05% 453
2023
Q4
$24.1M Sell
316,624
-532,131
-63% -$37M 0.04% 507
2023
Q3
$58.8M Sell
848,755
-29,983
-3% -$2.41M 0.1% 252
2023
Q2
$82.9M Buy
878,738
+219,657
+33% +$19.1M 0.13% 192
2023
Q1
$54.5M Sell
659,081
-386,210
-37% -$30.4M 0.09% 306
2022
Q4
$78M Sell
1,045,291
-980,627
-48% -$75.6M 0.13% 193
2022
Q3
$167M Sell
2,025,918
-440,154
-18% -$42.4M 0.3% 62
2022
Q2
$234M Sell
2,466,072
-126,724
-5% -$13.1M 0.39% 40
2022
Q1
$305M Sell
2,592,796
-60,930
-2% -$6.84M 0.39% 40
2021
Q4
$344M Buy
+2,653,726
New +$310M 0.38% 36

Other funds holding EW

Allspring Global Investments's EW Position: Q1 2026 in Review

Allspring Global Investments increased its Edwards Lifesciences (EW) stake by 221% in Q1 2026, buying an estimated $117M and bringing the position to 2,060,891 shares worth $167M. The position accounts for 0.28% of the portfolio, ranked #86.

Allspring Global Investments first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $344M in Q4 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Allspring Global Investments held 2,060,891 shares of Edwards Lifesciences worth $167M as of Q1 2026.
  • Allspring Global Investments bought 1,419,022 Edwards Lifesciences shares in Q1 2026, an estimated $117M.
  • Edwards Lifesciences made up 0.28% of Allspring Global Investments's portfolio in Q1 2026, its #86 holding.
  • Allspring Global Investments first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Edwards Lifesciences position peaked at $344M in Q4 2021.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.